Roy_01 schreef op 19 augustus 2019 18:02:
Kiadis Pharma Announces Investor Events for September 2019
Company announces Notice of Results for the six months ended June 30, 2019
Amsterdam, The Netherlands, August 19, 2019 – Kiadis Pharma N.V. (“Kiadis Pharma” or the “Company”) (Euronext Amsterdam and Brussels: KDS), a clinical stage biopharmaceutical company, announces its investor events in September 2019.
Kiadis will be issuing its interim results for the six months ended June 30, 2019 at 7.00am CEST / 6.00am BST / 1.00am EDT on Tuesday, September 10, 2019.
Kiadis’ management will host a webcast and conference call for analysts on Tuesday, September 10, 2019 at 3.00pm CEST / 2.00pm BST / 9.00am EDT. A copy of the announcement will be made available on the Kiadis Pharma website and details of the webcast and conference call will be made available within the Investor section of the company website. The webcast will be recorded, and a replay will be made available.
In addition, members of the Kiadis management team will attend the following investor events in September:
Hot in Healthcare
September 19, 2019, Amsterdam, The Netherlands
Kiadis will be participating in one-on-one meetings with investors on 19 September.
KBC Annual Healthcare Conference
September 26, 2019, Brussels, Belgium
Kiadis will be participating in one-on-one meetings with investors on 26 September.